Core Insights - Oscar Health is undergoing a significant transformation by tightening its insurance economics and redefining its technology platform, which is crucial for long-term investors [1][8] Company Overview - Oscar Health, Inc. is a technology-focused health insurance company providing various health insurance products and the +Oscar platform in the United States [5] - The company reported a total revenue of $11.29 billion and a net income of -$244.09 million for the trailing twelve months (TTM) [4] Recent Developments - GLYNN CAPITAL MANAGEMENT LLC sold 153,753 shares of Oscar Health, reducing its position to 2,856,025 shares valued at $54.06 million as of September 30, 2025 [2][3] - Despite the sale, Oscar Health remains the largest holding in GLYNN CAPITAL's portfolio, accounting for 17.06% of its 13F AUM [3][7] Financial Performance - As of November 11, 2025, Oscar Health's share price was $14.85, reflecting a one-year price change of 7.61%, which underperformed the S&P 500 by 4.52 percentage points [3][4] Strategic Focus - Oscar Health is improving its medical loss ratios and aligning pricing with membership risk, indicating a more stable operational structure [8] - The +Oscar platform is now integral to the company's strategy, allowing for scalable growth without significant overhead [8] Future Outlook - Investors are encouraged to monitor Oscar's ability to convert its current stability into predictable earnings and how it manages growth while expanding the +Oscar platform [9] - The company is positioned for a potential turnaround in the health insurance sector, with a clearer understanding of the key operational levers [9]